DKNG is trading 4.1% down at $23.52 as investors continue to digest weak 2026 revenue and EBITDA guidance and mounting competitive threats from prediction markets.

  • The stock’s drop follows a multi-month slide driven by disappointing long-term guidance and rising regulatory and tax pressures.
  • Concerns are mounting that emerging rivals like Polymarket and Kalshi could erode the company's long-term growth and market share.